Welcome to Lab Test Consult

You can log in and post your comments

Share your knowledge and experience!

Member Login
Lost your password?

FDA Clears Dako’s Companion Dx for Herceptin

December 16, 2011
By

Lu Wang has become program director of the National Human Genome Research Institute‘s new Mendelian Disorders Genome Centers program. Brad Ozenberger, NHGRI’s program director for Genomic Medicine, and Jean McEwen, program director for the Ethical, Legal, and Social Implications program, will oversee the institute’s new Clinical Sequencing Exploratory Research Projects initiative.


PrimeraDx this week announced that it has appointed Leroy Hood to its scientific advisory board. Hood has helped found several research and commercial enterprises, including Applied Biosystems (now part of Life Technologies), Amgen, and the Institute for Systems Biology, where he currently holds the position of president.


Gen-Probe this week said that board chairman Hank Nordhoff plans to retire at the end of the year. The company said that current President and CEO Carl Hull will replace Nordhoff as board chairman. Nordhoff held the offices of president and CEO from 1994 to 2009, and he will continue to serve the firm as a consultant until the end of 2012.

Separately, the company also disclosed in a document filed with the US Securities and Exchange Commission that senior VP of research and development Eric Lai has resigned from his position. No reason was given and no replacement was named in the filing.

Article source: http://www.genomeweb.com/mdx/fda-clears-dakos-companion-dx-herceptin

Share

Related posts:

  1. New York State Clears Rosetta Genomics’ Array-based Cancer of Unknown Primary Test
  2. Will Baylor’s New Next-Gen Sequencing Whole-Exome Test Sell?
  3. More Than One

Tags:



New post

Posts

January 2018
M T W T F S S
« Aug    
1234567
891011121314
15161718192021
22232425262728
293031  

Posts

Recent comments

    Contact Sign In

    Email Marketing You Can Trust